Ganglioside GM3 Conjugate Vaccine Data for Melanoma Immunotherapy

A 729-byte dataset from a 2026 study describes the design and immunological evaluation of a synthetic self-adjuvanting vaccine candidate targeting the GM3 antigen in cutaneous melanoma. The data likely contains results from immunological assays and tumor-challenge models, including IgG titers and survival metrics. The dataset was authored by Ruxin Liang and shared under a CC-BY-NC-4.0 license.

Use Cases

• Training models to predict vaccine immunogenicity based on conjugate design features mentioned in the description
• Analyzing the correlation between GM3-specific IgG titers and antitumor efficacy in mouse models
• Benchmarking the performance of synthetic lipid A mimetics as vaccine carriers against traditional adjuvants like KLH/Al

Strengths

• Dataset is directly linked to a peer-reviewed study describing specific immunological results.
• File size is 729.0 B, indicating a focused and potentially well-defined set of measurements.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Collection Method

Likely contains experimental results from the synthesis and immunological evaluation of a conjugate vaccine.

Freshness

Last updated 2026-05-04 09:05:04; freshness should be verified.